RS Research secures $12mn in Series A funding led by GEN Pharma

Biotechnology start-up RS Research has announced the completion of its $12mn Series A funding round. The investment is led by GEN Pharma, with participation with One Life Ventures and Eczacıbaşı Momentum.

Founded by Prof. Dr. Rana Sanyal and Sena Nomak, RS Research is developing novel targeted drug-delivery technology that aims to reduce the side effects of chemotherapy drugs, while increasing their effectiveness. ACT Venture Partners has backed RS Research since their first investment round in 2017. The new funding will be used to accelerate the clinical development processes of drug candidates in the company’s portfolio.

(TR) Read more about the story.
(ENG) Read more about the story.